Systemic hormone therapy reduces vasomotor symptoms for menopausal women, but its use among all U.S. women has decreased by as much as 80%. Instead, women have been seeking out other less regulated treatments for their symptoms, such as compounded hormone products.
WHI Results Often Misinterpreted
